Bristol Myers Squibb Drug Patent Portfolio

Bristol Myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol Myers Squibb News

Could Bristol Myers' Extensive Pipeline Be Crucial for Future Expansion? - TradingView

12 Mar, 2026

Reasons Behind Bristol Myers Squibb's Stock Surge in February - The Globe and Mail

09 Mar, 2026

BMY Sees 11.4% Increase Over the Past Month: Is It Time to Buy, Sell, or Hold? - The Globe and Mail

03 Mar, 2026

Impending Medication Shortage Poses Risks to Worldwide Healthcare Systems | Streamline Feed

26 Feb, 2026

See More